ClinicalTrials.gg
Drug

Procarbazine clinical trials

Also written Matulane and Natulan.

studies test it
35
open now
1
in phase 3
13
first study started
1994

How each study uses Procarbazine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Procarbazine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
22 Jul 1969 · MATULANE · NDA 016785 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

procarbazine hydrochloride
22
Procarbazine
7
Ibenzmethyzin
2

Brand

Matulane
4
Natulan
3

Development codes

NSC-77213
1

Studies by the year they started

33 studies that test it; most in 1998 (4)

Studies that test Procarbazine, by start year
YearStudies
19941
19962
19971
19984
19992
20003
20023
20042
20071
20082
20092
20101
20122
20131
20151
20162
20191
20211
20231

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
18
Phase 3
13
No phase
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 2 · Other 33

Alliance for Clinical Trials in Oncology (3) · M.D. Anderson Cancer Center (3) · Radiation Therapy Oncology Group (2) · University College, London (2) · Memorial Sloan Kettering Cancer Center (2) · University of Cologne (2) · Children's Oncology Group (2) · International Extranodal Lymphoma Study Group (IELSG) (1)

Often tested with

Tested in the same studies.

Vincristine (21) · Cyclophosphamide (12) · Etoposide (12) · Prednisone (12) · Lomustine (10) · Methotrexate (7) · Bleomycin (5) · Vinblastine (5)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 2 phase 3 studies under way

Procarbazine is the comparator. A study of two new drugs counts under both.

Studies

Open first, then newest update. How each study uses Procarbazine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 35

See all 35 studies that test Procarbazine →

Given beside what is tested · 8 — Procarbazine is usual care or a partner of the new treatment
As the comparator · 4 — what is tested is compared with Procarbazine

Codes

What other systems call Procarbazine · ClinicalTrials.gg INT008094

  • MeSH (NLM) D011344ProcarbazineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 35S93Y190KPROCARBAZINEConfirmed FDA, NLM, Wikidata
  • RxNorm 8702Confirmed FDA, Wikidata
  • Wikidata Q418656procarbazineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C62072ProcarbazineOne source FDA
  • DrugBank DB01168One source Wikidata

Also registered as procarbazine hydrochloride (UNII XH0NPH5ZX8 · RxNorm 66925).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.